A detailed history of Amundi transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Amundi holds 48,901 shares of TNDM stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,901
Previous 48,369 1.1%
Holding current value
$1.51 Million
Previous $1.95 Million 6.42%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.21 - $47.3 $18,731 - $25,163
532 Added 1.1%
48,901 $2.07 Million
Q2 2024

Aug 14, 2024

SELL
$30.43 - $53.43 $607,960 - $1.07 Million
-19,979 Reduced 29.23%
48,369 $1.95 Million
Q1 2024

May 15, 2024

BUY
$22.09 - $35.41 $1.51 Million - $2.42 Million
68,348 New
68,348 $2.42 Million
Q2 2023

Aug 14, 2023

SELL
$24.18 - $42.46 $2.61 Million - $4.58 Million
-107,875 Reduced 59.49%
73,446 $1.8 Million
Q1 2023

May 15, 2023

BUY
$35.86 - $46.5 $944,050 - $1.22 Million
26,326 Added 16.99%
181,321 $7.36 Million
Q4 2022

Feb 14, 2023

BUY
$35.49 - $56.15 $760,195 - $1.2 Million
21,420 Added 16.04%
154,995 $6.97 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $378,305 - $596,245
-8,645 Reduced 6.08%
133,575 $6.97 Million
Q2 2022

Aug 15, 2022

SELL
$53.22 - $123.09 $622,620 - $1.44 Million
-11,699 Reduced 7.6%
142,220 $7.62 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $2.49 Million - $3.66 Million
24,390 Added 18.83%
153,919 $18.9 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $32.4 Million - $42 Million
-274,033 Reduced 67.9%
129,529 $16.1 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $6.92 Million - $9.57 Million
-73,952 Reduced 15.49%
403,562 $48.2 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $36.8 Million - $47.8 Million
477,514 New
477,514 $46.5 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.98B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.